PHILADELPHIA (August 14, 2023) – Partners in Greater Philadelphia’s life sciences ecosystem are expanding their commitment to connecting a wider range of Philadelphians, including residents from di…
PHILADELPHIA—(August 9, 2023)— The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce the appointment of Alexander P…
Philadelphia – (August 8, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Joy Taylor to its Boar…
PHILADELPHIA — (JULY 26, 2023) — It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its connection to lymphomas. N…
PHILADELPHIA — (July 19, 2023) — Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, researchers from The…
Philadelphia—For the first time since 2019, The Wistar Institute opened its doors to host, in person, the 27th annual Jonathan Lax Memorial Award Lecture, which featured Deborah Persaud, M.D., Prof…
PHILADELPHIA—(June 22, 2023)—The Wistar Institute hosts its 27th Jonathan Lax Memorial Lecture Thursday, June 29th at 5:30 pm EST. For the first time since 2019, the signature event will be hosted …
PHILADELPHIA — (June 20, 2023) — When cancer that starts in the body metastasizes to the brain, it is almost always lethal, in part because so few treatment options exist. Now a new study by Wistar…
PHILADELPHIA — (May 26, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Sozi Tulante to its Board of Trustee…
PHILADELPHIA — (May 10, 2023) — GeneOne Life Science, Inc.(“GeneOne” KOSPI: 011000), a leading biopharmaceutical company specializing in developing nucleic-acid based treatments and novel small-mol…
